^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SB202190

    i
    Other names: SB202190
    Company:
    Amgen
    Drug class:
    MAPK inhibitor, p38 inhibitor
    Related drugs: